SC 13G Filing

Company

REGENERON PHARMACEUTICALS, INC.

Filed

June 10, 2020

Accession Number

0000315066-20-001593

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →